Advances in Brain Imaging Settle Debate Over Spread of Key Protein in Alzheimer’s
Researchers identify transneuronal spread of Tau protein in Alzheimer's disease
Researchers identify transneuronal spread of Tau protein in Alzheimer's disease
The drug works by targeting the protein responsible for the death of heart cells during an attack
Researchers gauge cell’s stiffness by applying the Stokes-Einstein equation to cellular motion patterns
Find out how precise affinity measurements can enable the generation of tailor-made binding proteins
Baculovirus cassette vector pAc-kappa-Fc for the expression of human, humanized or chimeric IgG(kappa) in insect cells and secretion of assembled antibodies into the supernatant. The vector derived from pAcUW51 is suitable for cloning of heavy and light chain Fab antibody gene fragments.
Baculovirus cassette vector pAc-lambda-CH3 for the expression of human, humanized or chimeric IgG(lambda) in insect cells and secretion of assembled antibodies into the supernatant. The vector derived from pAcUW51 is suitable for cloning of heavy and light chain scFv antibody gene fragments.
Baculovirus cassette vector pAc-lambda-Fc for the expression of human, humanized or chimeric IgG(lambda) in insect cells and secretion of assembled antibodies into the supernatant. The vector derived from pAcUW51 is suitable for cloning of heavy and light chain Fab antibody gene fragments.
Baculovirus cassette vector pAc-kappa-CH3 for the expression of human, humanized or chimeric IgG (kappa) in insect cells and secretion of assembled antibodies into the supernatant. The vector derived from pAcUW51 is suitable for cloning of heavy and light chain Fv antibody gene fragments.
In their tenth anniversary year, The Scientists’ Choice Awards saw more scientists and top technologies recognized than ever before
Learn about the six steps of CAR T cell production and the technology ensuring optimal cell delivery to patients
State-of-the-art PaperSpray technology simplifies mass spectrometry integration and improves efficiency
Dr. Joseph Hughes describes how WuXi Advanced Therapies scales up viral vectors to help customers expedite entry of gene and cell therapies into clinical trials
Dr. Jaroslav Fulneček, CEITEC MU, tells SelectScience about a new high-throughput assay for analysis of DNA-protein interactions